Hide

FocusBar

FeedbackFeedback
Subscribe to Premium Member
99.19 (1y: +24%)
Market Cap 1.56 B P/E(ttm)
Enterprise Value 1.43 B P/B 21.19
HTWR- NAS (USA)
Heartware International, Inc.
Not Rated
Top Ranked Predictable Companies
$99.19
Switch to:

GuruFocus Financial Strength Rank measures how strong a companyย’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength

vs
industry		 vs
history
Cash to Debt 1.025
HTWR's Cash to Debt is ranked lower than
69% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 3750.67 vs. HTWR: 1.025 )
HTWR' s 10-Year Cash to Debt Range
Min: 1.03   Max: No Debt
Current: 1.03
Equity to Asset 0.287
HTWR's Equity to Asset is ranked lower than
67% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 0.53 vs. HTWR: 0.287 )
HTWR' s 10-Year Equity to Asset Range
Min: 0.29   Max: 0.9
Current: 0.29
0.29
0.9
F-Score: 3
Z-Score: 6.16
M-Score: -2.24
GuruFocus Profitability Rank ranks how profitable a company is and how likely the companyย’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
ย•ย•3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rankย•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth

vs
industry		 vs
history
Operating margin (%) -70.00
HTWR's Operating margin (%) is ranked lower than
80% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 5.80 vs. HTWR: -70.00 )
HTWR' s 10-Year Operating margin (%) Range
Min: -8846.7   Max: -51.5
Current: -70
-8846.7
-51.5
Net-margin (%) -79.1
HTWR's Net-margin (%) is ranked lower than
81% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 3.25 vs. HTWR: -79.1 )
HTWR' s 10-Year Net-margin (%) Range
Min: -7157.8   Max: -53.3
Current: -79.1
-7157.8
-53.3
ROE (%) -128.6
HTWR's ROE (%) is ranked lower than
79% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 4.80 vs. HTWR: -128.6 )
HTWR' s 10-Year ROE (%) Range
Min: -128.6   Max: -17.5
Current: -128.6
-128.6
-17.5
ROA (%) -42.5
HTWR's ROA (%) is ranked lower than
80% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 3.40 vs. HTWR: -42.5 )
HTWR' s 10-Year ROA (%) Range
Min: -78.3   Max: -11
Current: -42.5
-78.3
-11
ROC (Joel Greenblatt) (%) -141.30
HTWR's ROC (Joel Greenblatt) (%) is ranked lower than
77% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 14.00 vs. HTWR: -141.30 )
HTWR' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -606.8   Max: -81.5
Current: -141.3
-606.8
-81.5
ยป HTWR's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades
Q2 2012

HTWR Guru Trades in Q2 2012

Chuck Royce Sold Out
Pioneer Investments 70,649 sh (-29.13%)
Manning & Napier Advisors, Inc 155,160 sh (-29.68%)
Steven Cohen 47,500 sh (-71.14%)
» More
Q3 2012

HTWR Guru Trades in Q3 2012

Manning & Napier Advisors, Inc 156,380 sh (+0.79%)
Steven Cohen Sold Out
Pioneer Investments 65,505 sh (-7.28%)
» More
Q4 2012

HTWR Guru Trades in Q4 2012

Steven Cohen 242,500 sh (New)
Manning & Napier Advisors, Inc 159,320 sh (+1.88%)
Pioneer Investments 55,519 sh (-15.24%)
» More
Q1 2013

HTWR Guru Trades in Q1 2013

Manning & Napier Advisors, Inc 159,420 sh (+0.06%)
Pioneer Investments Sold Out
Steven Cohen 163,900 sh (-32.41%)
» More
» Details

Insider Trades

Latest Guru Trades with HTWR

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
George Soros 2012-03-31 Sold Out 0.05%$65.86 - $75.83 $ 99.1951%0
George Soros 2011-12-31 Reduce -90%0.15%$58.78 - $70.56 $ 99.1952%15000
George Soros 2011-09-30 Add 900%0.15%$54.9 - $73.88 $ 99.1956%150000
George Soros 2011-06-30 New Buy0.02%$67 - $84.32 $ 99.1934%15000
Premium More recent guru trades are included for Premium Members only!!

Ratios

vs
industry		 vs
history
P/B 21.19
HTWR's P/B is ranked lower than
90% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 1.99 vs. HTWR: 21.19 )
HTWR' s 10-Year P/B Range
Min: 3.95   Max: 19.96
Current: 21.19
3.95
19.96
P/S 10.76
HTWR's P/S is ranked lower than
93% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 1.70 vs. HTWR: 10.76 )
HTWR' s 10-Year P/S Range
Min: 9.09   Max: 53.35
Current: 10.76
9.09
53.35
EV-to-EBIT -20.9
HTWR's EV-to-EBIT is ranked higher than
84% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 16.25 vs. HTWR: -20.9 )
HTWR' s 10-Year EV-to-EBIT Range
Min: 0   Max: 0
Current: -20.9

Valuation & Return

vs
industry		 vs
history
Price/Net Current Asset Value 40.6
HTWR's Price/Net Current Asset Value is ranked higher than
93% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 8.90 vs. HTWR: 40.6 )
HTWR' s 10-Year Price/Net Current Asset Value Range
Min: 19.7   Max: 39.3
Current: 40.6
19.7
39.3
Price/Tangible Book 24.4
HTWR's Price/Tangible Book is ranked higher than
95% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 3.80 vs. HTWR: 24.4 )
HTWR' s 10-Year Price/Tangible Book Range
Min: 4.9   Max: 20.2
Current: 24.4
4.9
20.2
Price/Median PS Value 1
HTWR's Price/Median PS Value is ranked higher than
76% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 0.80 vs. HTWR: 1 )
HTWR' s 10-Year Price/Median PS Value Range
Min: 0.8   Max: 1.6
Current: 1
0.8
1.6

Business Description

HeartWare International, Inc. was incorporated in Delaware on July 29, 2008 and became the successor issuer to HeartWare Limited, an Australian corporation, on November 13, 2008, as a result of the Australian Court approved redomiciliation of HeartWare Limited from Australia to Delaware. HeartWare is a medical device company engaged in developing implantable blood pumps for the treatment of advanced heart failure. The Company operates one reportable segment which includes the design, manufacture and marketing of medical devices for the treatment of advanced heart failure. The HeartWare Ventricular Assist System, which includes a left ventricular assist device, or blood pump, patient accessories and surgical tools, is designed to provide circulatory support for patients with advanced heart failure. Beyond the HeartWare System, the company is also evaluating its next device, the Miniaturized Ventricular Assist Device. The MVAD is based on the same technology platform as the HeartWare System but adopts an axial flow, rather than a centrifugal flow, configuration and is being developed in multiple configurations. The MVAD designs are currently at the preclinical stage and undergoing animal studies focused on minimally invasive implantation techniques and are each approximately one-third the size of the HVAD Pump. HEARTWARE, HVAD and MVAD, KRITON and various company logos are the trademarks of the Company, in the United States, Australia and other countries. The Company is subject to various federal, state and local laws and regulations, both in the United States, Europe and in Australia, relating to such matters as safe working conditions, laboratory and manufacturing practices and the use, handling and disposal of hazardous or potentially hazardous substances used in connection with its research and development work.
Company Website
SEC Reports
Industry: Medical Devices
Compare:MDT, SYK, SMA, ZMH, STJ
Traded in other countries:HIN.Australia, X1H.Germany
ยป More Articles for HTWR

Headlines

Articles On GuruFocus.com
Heartware International Inc (HTWR) CFO & COO David Mcintyre sells 2,857 Shares Feb 24 2011 
Heartware International Inc (HTWR) CFO & COO David Mcintyre sells 21,834 Shares Apr 30 2010 
Heartware International Inc (HTWR) CFO & COO David Mcintyre sells 5,271 Shares Mar 09 2010 
Heartware International Inc (HTWR) CFO & COO David Mcintyre sells 3,300 Shares Feb 26 2010 
Heartware International Inc (HTWR) CFO & COO David Mcintyre sells 4,967 Shares Jan 29 2010 
Heartware International Inc (HTWR) CFO & COO David Mcintyre sells 2,521 Shares Dec 07 2009 
Heartware International Inc (HTWR) CFO & COO David Mcintyre sells 1,580 Shares Dec 03 2009 
Heartware International Inc (HTWR) CFO & COO David Mcintyre sells 3,400 Shares Nov 30 2009 
Heartware International Inc (HTWR) CFO & COO David Mcintyre sells 3,415 Shares Nov 24 2009 
Heartware International Inc (HTWR) CFO & COO David Mcintyre sells 1,000 Shares Nov 18 2009 

More From Our Partners
Fresenius Teams with ApolloMed - Analyst Blog May 15 2013 - ZACKS

Personalized Checklist





Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names
Free 7-day Trial